外翻式与传统颈动脉内膜剥脱术后高血压的系统综述与荟萃分析
本研究系统检索文献比较外翻式颈动脉内膜剥脱术(E-CEA)与传统术式(C-CEA)术后血流动力学差异,纳入7项研究。荟萃分析显示E-CEA术后高血压风险显著增加(OR 2.75,95%CI 1.82-4.16),收缩压差值+12.92 mmHg,而C-CEA组低血压风险更高(OR 11.37)。
要点
- E-CEA术后高血压风险是C-CEA的2.75倍(95%CI 1.82-4.16)。
- E-CEA组术后收缩压较基线变化比C-CEA组高12.92 mmHg。
- C-CEA组需升压药治疗的低血压发生率显著更高(OR 11.37)。
核心结论
- E-CEA增加术后高血压风险,而C-CEA更常与低血压相关,术后早期应严密监测血压,尤其使用外翻技术时。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Cochrane CENTRAL和Web of Science至2016年6月,无语言限制。
- 纳入7项研究(4项非随机前瞻性、2项回顾性、1项随机对照试验的事后分析),偏倚风险低至中等。
- 术后研究观察期范围为1至6天。
主要发现
- E-CEA术后高血压需血管扩张剂治疗的合并OR为2.75(95%CI 1.82-4.16;I2=49.9%)。
- E-CEA与C-CEA对术后收缩压影响的组间加权平均差为+12.92 mmHg(95%CI 8.06-17.78;I2=93.6%;P<.0001)。
- C-CEA组需升压药治疗的低血压显著更高(合并OR 11.37;95%CI 1.95-66.46;I2=0%)。
- 术后并发症包括心肌梗死、卒中、颈部血肿或死亡无差异。
- 主要结局和低血压结局的证据强度评为中等,其他次要结局证据强度评为极低。
临床怎么用
- CEA术后至少早期应仔细监测血压,尤其采用外翻式CEA时,以及时发现并处理高血压。
- 传统CEA术后则需警惕低血压,必要时使用升压药。
局限性
- 纳入研究多为非随机设计,仅1项为随机对照试验的事后分析。
- 术后观察期定义在各研究间不一致(1至6天)。
- 收缩压分析的异质性很高(I2=93.6%)。
- 其他次要结局的证据强度极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Blood pressure (BP) instability after carotid endarterectomy (CEA) is a risk factor for cerebrovascular and cardiovascular complications. The role of the operative technique in the development of post-CEA hemodynamic instability is unclear. The primary goal of this study was to systematically review the literature to determine whether hypertension in the early postoperative period is dependent on the surgical technique used. METHODS: We searched MEDLINE, Cochrane CENTRAL, and Web of Science through June 2016 without restrictions to language or starting date. The interventions of interest were eversion CEA (E-CEA) compared with conventional CEA (C-CEA) with or without patch plasty. The primary outcome of interest was the incidence of postoperative need for vasodilator therapy because of hypertension in the early postoperative period, the duration of which was predefined in the individual studies. Secondary outcomes were the intergroup mean difference of the mean within-group changes of postoperative (24 hours) to baseline systolic BP, the incidence of hypotension requiring vasopressor therapy, and the rate of complications. The odds ratio (OR) of each binary outcome was pooled across studies with its 95% confidence interval (CI). For meta-analysis of continuous outcomes, the weighted mean differences with the corresponding 95% CIs were pooled. Strength of evidence of the outcomes was judged according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. RESULTS: We identified six studies, of which four were nonrandomized prospective and two retrospective with low to moderate risk of bias. In addition, results of a post hoc analyses of a randomized controlled trial were included, resulting in a total number of seven included studies. Duration of the postoperative study period ranged from 1 to 6 days. The meta-analysis of all studies regarding the primary outcome demonstrated increased rates of post-CEA hypertension after E-CEA (pooled OR, 2.75; 95% CI, 1.82-4.16; I2 = 49.9%). The pooled weighted intergroup mean difference between the E-CEA and C-CEA effects on postoperative systolic BP was +12.92 mm Hg (95% CI, 8.06-17.78; I2 = 93.6%; P < .0001). Hypotension was significantly higher in the C-CEA group (pooled OR, 11.37; 95% CI, 1.95-66.46; I2 = 0%). There was no difference in postoperative complications including myocardial infarction, stroke, neck hematoma, or death. Strength of evidence contributing to the primary outcome as well as the hypotension outcome was graded as moderate and that contributing to the other secondary outcomes was graded as very low. CONCLUSIONS: E-CEA increases the risk for post-CEA hypertension, whereas C-CEA is more often associated with hypotension, Careful BP monitoring at least in the early postoperative period after CEA is mandatory, especially when the eversion technique is used.
引用
- Demirel S, Goossen K, Bruijnen H, et al. Systematic review and meta-analysis of postcarotid endarterectomy hypertension after eversion versus conventional carotid endarterectomy. J Vasc Surg. 2017. PMID: 28236927. doi:10.1016/j.jvs.2016.10.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。